Genzyme Belgium Genzyme Corporate Search Contact us
HealthcarePatients & FamiliesPractical Info
A disease with many faces
 
Healthcare Professionals
About Lysosomal Storage Disease
Gaucher
Fabry
Disease Information
Management of Fabry Disease
Medical Information Services
Fabry Registry
Practical Info
Request Materials
MPS I
Pompe

 



 

Fabry Disease – Ophthalmologic Findings

Common ophthalmologic findings in Fabry disease include:

Whorled corneal opacities
Lenticular opacities
Vascular lesions of the conjunctivae and retina

Corneal opacities

Corneal opacities, beginning with a diffuse haziness and progressing to a characteristic "whorled" or "spoke-like" pattern, are found almost universally among classically affected hemizygotes and in a high proportion of heterozygous females (estimated to be approximately 70% [1]). This finding can be visualized through slit lamp microscopy. Corneal opacities do not impair vision.[2]


Distinctive Corneal Opacity in Fabry Disease

Lenticular opacities

Two types of lens opacities have been noted in Fabry patients: cream-colored anterior capsular deposits in the lens (sometimes distributed like a propeller), and whitish, granular spoke-like deposits on the posterior lens (referred to as Fabry cataracts). Fabry cataracts are more commonly observed than capsular deposits; they can be visualized by retroillumination.[2]

Lesions

Conjunctival and retinal vascular lesions resulting from the generalized disease process are common.[1]

Typical Conjunctival Involvement in Fabry Disease

Lesions may appear to be sausage-like, with markedly dilated vessels. The presence of several lesions of this type, which do not affect vision, may be pathognomonic for Fabry disease.[1]

References

1. Desnick RJ, Ioannou YA, Eng CM. Alpha-galactosidase A deficiency: Fabry disease. In: The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw Hill, 2001;3733-3774.

2. Sher NA, Letson RD, Desnick RJ. The ocular manifestations in Fabry's disease. Arch Ophthalmol. 1979;97:671-676

 
Print

PRINT

Bookmark

BOOKMARK




01/01/2007: Low bone density in Gaucher disease improves with CerezymeŽ

01/05/2007: Treatment for Pompe disease now available for Belgian patients

01/03/2006: Early treatment with FabrazymeŽ significantly slows progression of Fabry

More >



Lysosomal Storage Disorders
General information
Gaucher Disease
Fabry Disease
MPS I Disease
Pompe Disease